Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Top Cited Papers
- 10 October 2009
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (29), 4839-4847
- https://doi.org/10.1200/jco.2009.22.3271
Abstract
Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE). Rates of VTE, however, vary markedly among patients with cancer. Design This review focuses on recent data de...Keywords
This publication has 110 references indexed in Scilit:
- Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With CancerArchives of Internal Medicine, 2008
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancerJournal of Thrombosis and Haemostasis, 2008
- Silent venous thromboembolism before treatment in endometrial cancer and the risk factorsBritish Journal of Cancer, 2008
- Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinomaThrombosis Research, 2008
- High incidence of silent venous thromboembolism before treatment in ovarian cancerBritish Journal of Cancer, 2007
- Trousseau's syndrome: multiple definitions and multiple mechanismsBlood, 2007
- Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patientsBritish Journal of Haematology, 2007
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007
- Tissue factor expression as a possible determinant of thromboembolism in ovarian cancerBritish Journal of Cancer, 2007
- Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brainCancer, 2006